Healthy With HIV

This program will include a discussion of data that were presented in abstract form These data should be considered preliminary until published in a peer-reviewed journal

Introduction

Prevention of Cardiovascular Disease in PLWHIV

Challenges in Managing CVD in PLWHIV

PLWHIV Are Aging

Cardiovascular and Metabolic Complications in PLWHIV

PLWHIV Have Higher Rates of CV Risk Factors and Comorbidities

Higher Risk of Coronary Artery Disease (Myocardial Infarction)

Specific Needs in the Aging HIV population Depending on Gender (Men vs Women)

Cessation of Smoking Leads to a Better CV Risk Profile

The Risk of MI Decreased With Smoking Cessation in HIV+ DAD Study

Hypertension (HTN)

Preventing CVD

Underused Guideline-Recommended Cardiovascular Care in PLWHIV

DDI and Polypharmacy

Concluding Remarks

Concluding Remarks (cont)

Low BMD, Osteoporosis, and Preservation of Bone Health in PLWHIV

Why Is Low BMD Important in PLWHIV?

Classic Risk Factors for Reduced BMD

ART and Low BMD

Non-HIV Risk Factors for Fracture

Measuring BMD

Managing Low BMD

Concluding Remarks

Renal Impairment in PLWHIV

Spectrum of Renal Disease in PLWHIV

Spectrum of Renal Disease in PLWHIV (cont)

Evolution of Comorbidities Among PLWHIV

Risk Factors for CKD in PLWHIV

CVD Is a Risk Factor for CKD: Strong Reciprocal Relationship

Other Risk Factors for CKD

Prevention of Renal Disease

Acute Renal Failure

Impact of Long-Term cART on Renal Impairment

Screening and Diagnosis of Renal Impairment in PLWH

Monitoring Renal Function and Pathology: Glomerular Filtration

Monitoring Renal Function and Pathology (cont)

Monitoring Renal Function and Pathology (cont)

Calculating Renal Risk

Concluding Remarks

Series Conclusion

Abbreviations

Abbreviations (cont)

Abbreviations (cont)

Abbreviations (cont)